Clinical Neuroscience

[Catamnosis of children with elective mutism]

LÓRÁND Blanka1

JANUARY 01, 1961

Clinical Neuroscience - 1961;14(01)

[The author describes 11 cases of elective mutism - with particular reference to catamnestic data recorded years later. The symptom usually comes to attention in preschool or during school enrolment. It is strikingly often associated with vegetative dystonia, enuresis and mental retardation. Although polyaetiological factors are frequently present in the history, the author is under the impression that in a significant proportion of cases, a congenitally reduced speech ability is primarily responsible for the manifestation of e.m. The therapeutic approach varies according to the type of reaction and pathogenesis. He concludes that, when sufficient time was available, the therapeutic outcome was durable in the vast majority of cases (7 complete cures, 2 improvements). The catamnestic monitoring of the therapeutic outcome also serves the purpose of facilitating and providing empirical support for the prognosis.]

AFFILIATIONS

  1. Országos Ideg-és Elmegyógyintézet Gyermekpsychiatriai Osztály

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

[Malignant angioblastoma spreading between the soft tissues ("Lindau disease") ]

POTONDI András

[The author describes a case of a rapidly progressive, fatal cerebellar solid angioblastoma (Lindau), which spread diffusely along the blood vessels and between the soft tissues. He briefly reviews the literature on the subject, which did not find angioblastoma spreading in a similar manner. ]

Clinical Neuroscience

[Intravenous urea: new agent for intracranial pressure increase in intracranial pressure]

ZAPPE Lajos, VIDOVSZKY Tamás

[Our experience, which we have presented in the form of a preliminary bulletin because of the small number of cases, suggests that i.v. urea will be a much more effective and reliable tool than hypertonic solutions (dextrose, etc.) in the treatment of intracranial hypertension. The development of a side-effect-free home preparation is currently underway; we will report on clinical trials of this on larger material and on studies of the mechanism of action. ]

Clinical Neuroscience

[Our experience with Urevert, Report on our surgical observations ]

GOMBI Róza, HULLAY József

[The authors describe their experience with Urevert, a new intracranial pressure reliever. It was used to reduce increased intracranial pressure caused by brain tumours (4), ruptured aneurysms (2) and subdural haematoma (1) in 7 patients. They observed that Urevert is an easy to administer and accurately dosed dehydrating agent. It is excellent for reducing increased intracranial pressure. It reaches its maximum effect within 1-2 hours and can therefore be administered primarily as a preoperative preparation. No unpleasant side effects have been observed. Indication is wide, contraindications are active intracranial haemorrhages and various severe liver and kidney diseases.]

Clinical Neuroscience

[Max Nonne]

KÖRNYEY István

[The author reports on Max Nonne's life. ]

Clinical Neuroscience

[Retroolivar softenings as vertebralis complications of angiography]

ASZALÓS Zoltán, CSATÁRY Zoltán

[In two cases of attempted carotid AG, the contrast material entered the vertebral artery, resulting in fatal retroolivar atrophy and haemorrhage, both of which were associated with the posterior blood supply area of the cerebellar inf. In one case very pronounced, in the other mild vascular lesions may have been a predisposing factor for AG complications. No such localized complication has been reported in the literature. ]

All articles in the issue

Related contents

Clinical Neuroscience

Cases of inborn errors of metabolism diagnosed in children with autism

CAKAR Emel Nafiye, YILMAZBAS Pınar

Autism spectrum disorder is a neurodevelopmental disorder with a heterogeneous presentation, the etiology of which is not clearly elucidated. In recent years, comorbidity has become more evident with the increase in the frequency of autism and diagnostic possibilities of inborn errors of metabolism. One hundred and seventy-nine patients with diagnosis of autism spectrum disorder who presented to the Pediatric Metabolism outpatient clinic between 01/September/2018-29/February/2020 constituted the study population. The personal information, routine and specific metabolic tests of the patients were analyzed retrospectively. Out of the 3261 patients who presented to our outpatient clinic, 179 (5.48%) were diagnosed with autism spectrum disorder and were included in the study. As a result of specific metabolic examinations performed, 6 (3.3%) patients were diagnosed with inborn errors of metabolism. Two of our patients were diagnosed with classical phenylketonuria, two with classical homocystinuria, one with mucopolysaccharidosis type 3D (Sanfilippo syndrome) and one with 3-methylchrotonyl Co-A carboxylase deficiency. Inborn errors of metabolism may rarely present with autism spectrum disorder symptoms. Careful evaluation of the history, physical examination and additional findings in patients diagnosed with autism spectrum disorder will guide the clinician in the decision-making process and chose the appropriate specific metabolic investigation. An underlying inborn errors of metabolism may be a treatable cause of autism.

Clinical Neuroscience

[Is the implementation of Vojta therapy associated with faster gross motor development in children with cerebral palsy? ]

SANZ-MENGIBAR Jose Manuel , MENENDEZ-PARDIÑAS Monica , SANTONJA-MEDINA Fernando

[Vojta therapy has been reported as clinically beneficial for strength, movement and gross motor activities in individual cases and is being included within the second of three levels of evidence in interventions for cerebral palsy. The goal of this study is to understand the effect of Vojta therapy on the gross motor function. Our clinical trial followed a one group, pre-post design to quantify rates of changes in GMFM-88 after a two-months period undergoing Vojta therapy. A total of 16 patients were recruited. Post-intervention acceleration rates of GMFM-88-items acquisition (0.005; p<0.001) and Locomotor Stages (1.063; p<0.0001) increased significatively following Vojta the­rapy intervention. In this study, Vojta therapy has shown to accelerate the acquisition of GMFM-88-items and Loco­motor Stages in children with cerebral palsy younger than 18 months. Because functional training was not utilised, and other non-Vojta therapy intervention did not influence the outcome, Vojta therapy seems to activate the postural control required to achieve uncompleted GMFM-88-items. ]

Journal of Nursing Theory and Practice

[The Effects of the Children’s Temperament and their Parents’ Dental Fear on developing Dental Fear]

APRÓ Zoltán, NÉMETH Anikó

[The aim the present study was to assess the level of dental fear among 5-7 years old children and its correlations with dental-hygienic habits and their temperament. Furthermore, the relationship of the dental fear of parents and children was also analysed. This cross-sectional study was conducted by the means of a self-constructed questionnaire in 2017. The responses of 70 people were analysed with the help of SPSS 22.0; descriptive statistics, 2-sample T-probes, Mann-Whitney probes, analyses of variance and correlations were calculated (p<0.05). High level of dental fear was detected by 30% of the included children. There was no correlation between the dental fear of the parents and their children’s. Dental fear had no effect on the frequency of tooth-brushing. Children’s dental fear had no correlation with either previous painful experiences at the dentist’s or the temperament of the child. Dental fear is present among children and not only family but dental hygienists might play an important role in reducing it. ]

Clinical Neuroscience

[Sleep habits among preschool- and schoolchildren]

FUSZ Katalin, RITECZ Bernadett, BALOGH Brigitta, TAKÁCS Krisztina, SOMLAI Eszter, RAPOSA L. Bence, OLÁH András

[Objective - Our aim is to evaluate sleep habits, sleep quality and influencing factors among preschool- and schoolchildren. Method - Two questionnaires were recorded. Questionnaire 1 dealt with sleeping habits, breastfeeding and health behavior of preschool children and infant, and it contained the abbreviated version of the Children’s Sleep Habits Questionnaire. Questionnaire 2 dealt with health behavior and the application of sleep hygiene rules, as well as it contained the Athens Insomnia Scale. Subjects - We assessed a total of 1063 questionnaires: 516 kindergarten children participated in our online survey across the country; 547 primary and secondary school students participated in the 2nd questionnaire survey in Szolnok. Results - Parents’ observation shows that the average nighttime sleeping time of kindergarten children is 10 hours 20 minutes on weekdays and 10 hours 36 minutes on weekends. The most popular sleeping habits in kindergarten age: teal reading (65.1%) and co-sleeping (42.8%). Parents of infants used breastfeeding (50.4%) and rocking (43.2%) most frequently before sleep. Co-sleeping has a positive influence on the length of lactation. Among the preschool sleeping habits we have proved a number of positive effects of teal reading, while watching television have negative effects. The sleep quality of school-age children according to the Athens Insomnia Scale is 6.11 points (SD: 4.11), 19% of the children are insomniac. Their sleep time is 7 hours 31 minutes on weekdays and 9 hours 30 minutes on weekends. The usage of good health behavior and sleep hygiene rules positively influence sleep quality and sleep duration. Conclusions - With our results, we would like to draw the attention of children and parents to the importance of sleeping and using sleep hygiene rules.]

Clinical Neuroscience

[Family planning in multiple sclerosis: conception, pregnancy, breastfeeding]

RÓZSA Csilla

[Family planning is an exceptionally important question in multiple sclerosis, as women of childbearing age are the ones most often affected. Although it is proven that pregnancy does not worsen the long-term prognosis of relapsing-remitting multiple sclerosis, many patients are still doubtful about having children. This question is further complicated by the fact that patients – and often even doctors – are not sufficiently informed about how the ever-increasing number of available disease-modifying treatments affect pregnancies. Breastfeeding is an even less clear topic. Patients usually look to their neurologists first for answers concerning these matters. It falls to the neurologist to rationally evaluate the risks and benefits of contraception, pregnancy, assisted reproduction, childbirth, breastfeeding and disease modifying treatments, to inform patients about these, and then together come to a decision about the best possible therapeutic approach, taking the patients’ individual family plans into consideration. Here we present a review of relevant literature adhering to international guidelines on the topics of conception, pregnancy and breastfeeding, with a special focus on the applicability of approved disease modifying treatments during pregnancy and breastfeeding. The goal of this article is to provide clinicians involved in the care of MS patients with up-to-date information that they can utilize in their day-to-day clinical practice. ]